Matches in Wikidata for { <http://www.wikidata.org/entity/Q28564458> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q28564458 description "2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած" @default.
- Q28564458 description "2005 թվականի ապրիլին հրատարակված գիտական հոդված" @default.
- Q28564458 description "article scientifique publié en 2005" @default.
- Q28564458 description "artículu científicu espublizáu en 2005" @default.
- Q28564458 description "im April 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q28564458 description "scientific journal article" @default.
- Q28564458 description "vedecký článok (publikovaný 2005/04/07)" @default.
- Q28564458 description "vědecký článek publikovaný v roce 2005" @default.
- Q28564458 description "wetenschappelijk artikel (gepubliceerd op 2005/04/07)" @default.
- Q28564458 description "наукова стаття, опублікована у квітні 2005" @default.
- Q28564458 description "مقالة علمية (نشرت في 7-4-2005)" @default.
- Q28564458 name "Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand" @default.
- Q28564458 name "Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand" @default.
- Q28564458 name "Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand" @default.
- Q28564458 type Item @default.
- Q28564458 label "Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand" @default.
- Q28564458 label "Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand" @default.
- Q28564458 label "Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand" @default.
- Q28564458 prefLabel "Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand" @default.
- Q28564458 prefLabel "Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand" @default.
- Q28564458 prefLabel "Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand" @default.
- Q28564458 P1433 Q28564458-7AEE2100-D4FE-4067-B75E-CF016989E542 @default.
- Q28564458 P1476 Q28564458-CF0512F7-8BB7-4B1B-B8CC-E96D0C4B9D6E @default.
- Q28564458 P2093 Q28564458-14CBD1CA-1A55-475A-9D2F-7CE5504F157F @default.
- Q28564458 P2093 Q28564458-6AD30C4F-7679-45BF-B2C7-9C4B63B6DC8B @default.
- Q28564458 P2093 Q28564458-819ADAB5-1542-445F-B59D-DA61CFF97ABE @default.
- Q28564458 P2093 Q28564458-9BAAD9CF-D75C-401A-9E7C-F932E6BA2899 @default.
- Q28564458 P2093 Q28564458-AC015F64-1A8E-47EC-B9FE-CECBD51BFBC3 @default.
- Q28564458 P2093 Q28564458-B3C75C0F-7527-4EB0-90C0-86AE6DB75AF6 @default.
- Q28564458 P2093 Q28564458-E1D0E6FA-0349-40A1-A6F4-15558FC3608F @default.
- Q28564458 P304 Q28564458-D851A3BA-06AD-486A-88BD-5BEDB8622D1B @default.
- Q28564458 P31 Q28564458-58CD12CF-7082-4C98-8D3C-7DF5D154A01C @default.
- Q28564458 P356 Q28564458-4560EBEA-49A1-4BEA-BF6A-7A0E126F9C7A @default.
- Q28564458 P407 Q28564458-6FAF7591-01A8-437F-B9DE-5F22ED6881F9 @default.
- Q28564458 P433 Q28564458-F4AD3628-39F8-4A20-B21A-6F5D41E066D5 @default.
- Q28564458 P478 Q28564458-D2F86DBE-D720-4CB4-A696-1D6D5C56F8A4 @default.
- Q28564458 P577 Q28564458-761536AC-005A-4E00-9742-F2C5BDF1C1B5 @default.
- Q28564458 P698 Q28564458-1AC06ABD-B3D5-46E1-B21B-BA9AA5EAA5BD @default.
- Q28564458 P921 Q28564458-4D48E54B-2F67-4655-A9B3-B858148AAB9A @default.
- Q28564458 P356 JM049188D @default.
- Q28564458 P698 15801858 @default.
- Q28564458 P1433 Q900316 @default.
- Q28564458 P1476 "Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand" @default.
- Q28564458 P2093 "Hiroshi Tanaka" @default.
- Q28564458 P2093 "Hiroyuki Satoh" @default.
- Q28564458 P2093 "Jiro Katayama" @default.
- Q28564458 P2093 "Kenji Hashimoto" @default.
- Q28564458 P2093 "Masakazu Fujio" @default.
- Q28564458 P2093 "Ryo Tatsumi" @default.
- Q28564458 P2093 "Shin-Ichi Takanashi" @default.
- Q28564458 P304 "2678–2686" @default.
- Q28564458 P31 Q13442814 @default.
- Q28564458 P356 "10.1021/JM049188D" @default.
- Q28564458 P407 Q1860 @default.
- Q28564458 P433 "7" @default.
- Q28564458 P478 "48" @default.
- Q28564458 P577 "2005-04-07T00:00:00Z" @default.
- Q28564458 P698 "15801858" @default.
- Q28564458 P921 Q180623 @default.